Julia Chu

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Patients will be followed for adverse events following each infusion of ADV CTLs

Recruiting

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Patients will be monitored for adverse events following the administration of CMV CTLs

Recruiting

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Patients will be monitored for adverse events following each CTL infusion

Recruiting